All hospitalized patients who are COVID-19 positive (includes confirmed and presumptive cases when testing is not available).

1) Initial presenting symptoms are documented in the population of interest.
2) Co-morbidities are documented in the population of interest.
3) COVID test sample collection and result times are documented in the population of interest.
4) When intubation is required, staff document levels of use (level 1-surgical mask, level 2-N95, level 3- Powered air-purifying respirator (PAPR)).
5) Recommended treatments for severe and critical COVID-19 patients are received early after hospital admission.

1) Number and percentage of patients with initial presenting symptoms are documented in the history and physical (H&P) record.
2) Number and percentage of patients with a complete past medical history (PMH) are documented in the H&P.
3) Number and percentage of patients with smoking history are documented in the H&P.
4) Documented number and percentage of patients with COVID test sample collection and result times.
5) Number and percentage of patients requiring intubation procedures who have documentation of level of PPE used by staff (level 1-surgical mask, level 2-N95, level 3-PAPR).
6) Number and percentage of severe and critical patients receiving remdesivir in < 24 hrs and < 48 hrs.
7) Number and percentage of severe and critical patients receiving dexamethasone in < 24 hrs and < 48 hrs.
8) Number and percentage of severe and critical patients receiving COVID convalescent plasma (CCP) in < 24 hrs and < 48 hrs.

The previous sections constitute the minimum criteria for PI monitoring of this CPG. System reporting will be performed annually; additional PI monitoring and system reporting may be performed as needed.
The JTS Chief, JTS Program Manager, and the JTS PI Branch will perform the system review and data analysis.

It is the trauma team leader’s responsibility to ensure familiarity, appropriate compliance, and PI monitoring at the local level with this CPG.